QIAGEN Acquires Genoox

Zoetis to Acquire Neogen’s Animal Genomics Business for $160 Million

March 3, 2026

Healthcare Services

Zoetis announced it has entered into a definitive agreement to acquire Neogen Corporation’s animal genomics business for $160 million, subject to customary closing adjustments. The deal is intended to strengthen Zoetis’ leadership in Precision Animal Health by integrating Neogen’s genomic technologies and data solutions to expand predictive insights and individualized care.

SeqOne Acquires Congenica

September 2, 2025

Software

SeqOne has acquired Congenica, a UK clinical genomics software company spun out of the Wellcome Sanger Institute, creating one of the largest pure‑play genomics software firms serving over 160 laboratories in 30+ countries. The combined business will integrate SeqOne's AI-driven NGS analysis platform with Congenica's clinical decision‑support tools to accelerate rare disease diagnoses and personalized cancer therapies while expanding SeqOne's UK presence.

QIAGEN Acquires Verogen

January 9, 2023

Biotechnology

QIAGEN completed the acquisition of Verogen for $150 million in cash, bringing Verogen’s NGS-based human identification and forensic genomics products and the GEDmatch database into QIAGEN’s forensics portfolio. The deal gives QIAGEN exclusive distribution rights for the MiSeq FGx forensic sequencer version and is intended to expand QIAGEN’s capabilities and commercial footprint in the fast-growing Human ID/forensics market.

Eurobio Scientific Acquires GenDx (Genome Diagnostics B.V.)

October 4, 2022

Biotechnology

Paris-based Eurobio Scientific has acquired all outstanding shares of Dutch transplant diagnostics specialist GenDx (Genome Diagnostics B.V.), following a share purchase agreement signed on August 17. The acquisition expands Eurobio's molecular diagnostics portfolio in transplantation and secures the company legacy with proceeds funding a GenDx foundation established by the founders.

Bionano Genomics Acquires BioDiscovery

October 12, 2021

Software

Bionano Genomics agreed to acquire BioDiscovery, a provider of NxClinical genomics analysis software, in a deal worth up to $100 million in cash and equity. The acquisition will integrate BioDiscovery's platform-agnostic analysis and reporting tools with Bionano's optical genome mapping technology to accelerate variant analysis and broaden Bionano's market reach; BioDiscovery founder Soheil Shams will join Bionano as Chief Informatics Officer.

Twist Bioscience Acquires iGenomX

June 30, 2021

Biotechnology

Twist Bioscience acquired iGenomX, a developer of high-throughput multiplex NGS library preparation tools, to expand its NGS workflow capabilities and accelerate customer conversion from microarray genotyping to sequencing-based genotyping. The deal consideration was $35 million (combination of cash and Twist stock, plus up to $5 million contingent stock), and Twist expects modest near-term financial impact with incremental revenue from the acquired business in fiscal 2023.